GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifecare ASA (OSL:LIFE) » Definitions » EBITDA Margin %

Lifecare ASA (OSL:LIFE) EBITDA Margin % : -573.95% (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Lifecare ASA EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Lifecare ASA's EBITDA for the six months ended in Dec. 2023 was kr-19.74 Mil. Lifecare ASA's Revenue for the six months ended in Dec. 2023 was kr3.44 Mil. Therefore, Lifecare ASA's EBITDA margin for the quarter that ended in Dec. 2023 was -573.95%.


Lifecare ASA EBITDA Margin % Historical Data

The historical data trend for Lifecare ASA's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecare ASA EBITDA Margin % Chart

Lifecare ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only - - - -215.70 -932.99

Lifecare ASA Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -137.44 - -573.95

Competitive Comparison of Lifecare ASA's EBITDA Margin %

For the Medical Devices subindustry, Lifecare ASA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifecare ASA's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lifecare ASA's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Lifecare ASA's EBITDA Margin % falls into.



Lifecare ASA EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Lifecare ASA's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-32.095/3.44
=-932.99 %

Lifecare ASA's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-19.744/3.44
=-573.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lifecare ASA  (OSL:LIFE) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Lifecare ASA EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Lifecare ASA's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifecare ASA (OSL:LIFE) Business Description

Traded in Other Exchanges
Address
Ytrebygdsvegen 215, Blomsterdalen, Bergen, NOR, 5258
Lifecare AS is engaged in the research and development of medical sensors for health monitoring. The company is engaged in the development, testing, and introduction of the first long-term implantable microsensor to give persons with diabetes a modern tool for the monitoring of glucose levels. It develops Sencell, a long-term implantable microsensor to give persons with diabetes a tool for monitoring of glucose levels.

Lifecare ASA (OSL:LIFE) Headlines

No Headlines